|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1991-9-26
|
|
pubmed:abstractText |
The authors evaluated the levels of a mucinous-like carcinoma antigen (M.C.A.) in the serum of 105 follow-up patients with breast carcinoma by means of an enzyme immunoassay. The negative/positive cut-off level determined in a group of healthy women was 13.2 U/ml. 80 patients turned out to be free disease, while 25 patients showed relapse or metastasis. High levels of MCA were observed in 72.0% of the patients with renewal of the neoplastic disease as well as in 12.5% of the free disease subjects. The EIA method appeared to have a good specificity (87.5%) and a fair test efficiency (83.8%). On the contrary, its sensitivity (72.0%) and its predictive value (64.3%) were not completely satisfactory. Therefore we think the matter needs to be studied more deeply and so does the case-report.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0021-2547
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
69
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
315-8
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:2102115-Adult,
pubmed-meshheading:2102115-Aged,
pubmed-meshheading:2102115-Aged, 80 and over,
pubmed-meshheading:2102115-Antigens, Neoplasm,
pubmed-meshheading:2102115-Antigens, Tumor-Associated, Carbohydrate,
pubmed-meshheading:2102115-Breast Neoplasms,
pubmed-meshheading:2102115-Female,
pubmed-meshheading:2102115-Follow-Up Studies,
pubmed-meshheading:2102115-Humans,
pubmed-meshheading:2102115-Immunoenzyme Techniques,
pubmed-meshheading:2102115-Mastectomy,
pubmed-meshheading:2102115-Middle Aged,
pubmed-meshheading:2102115-Neoplasm Metastasis,
pubmed-meshheading:2102115-Neoplasm Recurrence, Local,
pubmed-meshheading:2102115-Sensitivity and Specificity,
pubmed-meshheading:2102115-Tumor Markers, Biological
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
Clinical value of a new tumor marker (M.C.A.) in the breast cancer follow-up.
|
|
pubmed:affiliation |
Centro Tumori, U.L.S.S. 8, Vicenza, Italy.
|
|
pubmed:publicationType |
Journal Article
|
